Particularly, many studies and meta-analyses reported that, on average, TRD patients have increased serum levels of pro-inflammatory molecules including interleukin-6 (IL-6), tumor necrosis factor (TNF) and C-reactive protein (CRP) [10,11]. This evidence concerns the gene CRP and treatment resistant depression.